Results 21 to 30 of about 24,304 (148)

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia

open access: yesFrontiers in Cell and Developmental Biology, 2022
Acute myeloid leukemia (AML) is a serious, life-threatening hematological malignancy. The treatment outcome of relapsed or refractory AML patients remains dismal, and new treatment options are needed.
Wei Yu   +6 more
doaj   +1 more source

Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case

open access: yesJournal of Translational Medicine, 2022
Background People living with HIV/AIDS (PLWHA) show a reduced incidence for three cancer types, namely breast, prostate and colon cancers. In the present study, we assessed whether a molecular mimicry between HIV epitopes and tumor associated antigens ...
Carmen Manolio   +10 more
doaj   +1 more source

Myopia disease mouse models: a missense point mutation (S673G) and a protein-truncating mutation of the Zfp644 mimic human disease phenotype

open access: yesCell & Bioscience, 2019
Zinc finger 644 (Zfp644 in mouse, ZNF644 in human) gene is a transcription factor whose mutation S672G is considered a potential genetic factor of inherited high myopia.
Katarzyna I. Szczerkowska   +17 more
doaj   +1 more source

The epigenetic modifier Fam208a is required to maintain epiblast cell fitness

open access: yesScientific Reports, 2017
Gastrulation initiates with the formation of the primitive streak, during which, cells of the epiblast delaminate to form the mesoderm and definitive endoderm.
Shohag Bhargava   +8 more
doaj   +1 more source

In silico design and evaluation of a multi-epitope and multi-antigenic African swine fever vaccine

open access: yesImmunoInformatics, 2022
African Swine Fever (ASF) is caused by a highly contagious and fatal hemorrhagic virus, which in 2019 alone in Asia, has killed 8 million pigs with a devastating estimated economic loss amounting to $130 billion.
Ara Karizza G. Buan   +3 more
doaj  

CD166-specific CAR-T cells potently target colorectal cancer cells

open access: yesTranslational Oncology, 2023
Chimeric antigen receptor (CAR) T-cell therapy is emerging as an effective cancer treatment, such as for hematological malignancies, however its effectiveness as an approach to treat solid tumors, such as in colorectal cancer (CRC), remains to be better ...
Shuai He   +8 more
doaj  

Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells

open access: yesJournal of Translational Medicine, 2023
Background Glioblastoma (GBM) is recognized as among the most aggressive forms of brain tumor. Patients typically present with a five-year survival rate of less than 6% with traditional surgery and chemoradiotherapy, which calls for novel immunotherapies
Shijie Wang   +6 more
doaj   +1 more source

Application of a Spacer-nick Gene-targeting Approach to Repair Disease-causing Mutations with Increased Safety

open access: yesBio-Protocol, 2023
The CRISPR/Cas9 system is a powerful tool for gene repair that holds great potential for gene therapy to cure monogenic diseases. Despite intensive improvement, the safety of this system remains a major clinical concern.
Ngoc Tung Tran   +5 more
doaj   +1 more source

Ultrasensitive gene regulation by positive feedback loops in nucleosome modification

open access: yesMolecular Systems Biology, 2008
Eukaryotic transcription involves the synergistic interaction of many different proteins. However, the question remains how eukaryotic promoters achieve ultrasensitive or threshold responses to changes in the concentration or activity of a single ...
Kim Sneppen   +2 more
doaj   +1 more source

ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis

open access: yesMolecular Medicine, 2020
Background Breast cancer (BC) is a common malignant tumor with poor prognosis. Angiogenesis is related to the growth and progression of solid tumors and associated with prognosis.
Xuan Li   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy